Skip to content

Evaluation of efficacy and safety of ciprofloxacin impregnated catheters in preventing catheter associated urinary tract infections in patients requiring short-term catheterization- An open labelled clinical trial.

Evaluation of efficacy and safety of ciprofloxacin impregnated catheters in preventing catheter associated urinary tract infections in patients requiring short-term catheterization-An open labelled clinical trial. - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/074256
Enrollment
100
Registered
2024-09-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Ciprofloxacin impregnated foleys catheter: Ciprofloxacin intravenous solution 200 mg in 100 ml Control Intervention1: Standard foleys catheter: Standard foleys catheter

Sponsors

Krishna Parmar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Male or female patients of age of 18 years or above. 2. Patients who need an indwelling urinary catheter as a method of bladder drainage for at least 7 days. 3.Patients who are willing to participate in the study and give their written informed consent

Exclusion criteria

Exclusion criteria: 1.Patients who can benefit from other method of bladder drainage such as intermittent catheterization, suprapubic drainage. 2. Patients with urinary tract infection at the time of admission. 3.Current antibiotic use or use within 7 days prior to inclusion based on past history. 4. Known allergy to latex, silver salts or hydrogels.5. Patients with surgical interventions in the urinary tract that may interfere, at the investigator criteria, with the study results. 5. Pregnant or breastfeeding woman. 6. Pyschiatric patients 7. Patients with altered consciousness

Design outcomes

Primary

MeasureTime frame
Incidence of catheter associated urinary tract infection in ciprofloxacin impregnated catheterTimepoint: 2 months

Secondary

MeasureTime frame
Incidence of Asymptomatic Urinary Tract infection in ciprofloxacin impregnated foleys catheterTimepoint: 2 months

Countries

India

Contacts

Public ContactDr Girish Jatkar

Shri Vasantrao Naik Medical College Yavatmal

gjatkar9@gmail.com9822363140

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026